ECS Botanics is an Australian leader in low-cost medicinal cannabis production, utilising innovative cultivation methods to meet EU-GMP (Good Manufacturing Practice) standards.

Its pharmacy-grade manufacturing facility prioritises sustainability, supplying pharmaceutical-grade products to Australia, the UK, Germany, Switzerland, and New Zealand.

ECS holds one of five licences from the Therapeutic Goods Administration for PIC/S GMP (Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme) certified products and employs a capital-efficient B2B model in a prime cannabis growing region along the Murray River in Victoria, benefiting from optimal climate conditions.

This results in high-quality cannabinoid products while minimising environmental impact, making ECS Botanics a key player in the industry.

KEY PEOPLE

  • Arthur Sun, Chief Financial Officer

    read more

  • Alex Keach, Managing Director

    read more

  • Nan-Maree Schoerie, Executive Director

    read more

  • Jeremy King, Non Executive Director

    read more

  • Michael Nitsche, Non Executive Director

    read more

RELATED STOCKHEAD STORIES